DENVER, Dec. 2 Global Med Technologies(R), Inc.("Global Med" or the "Company") (OTC Bulletin Board: GLOB), an internationale-Health, medical information technology company, today announced that itsEuropean subsidiary, Inlog S.A., has licensed its EdgeTrack TransfusionSoftware, marketed as "Hemo Serveur" in France, to 21 Assistance Publique -Hopitaux de Paris ("AP-HP") hospitals, representing 23,000 patient beds. ForGlobal Med, this project represents over $2 million, at current exchangerates, in software and services.
The computerization of blood transfusion in these 21 hospitals is part ofthe AP-HP's "Clinical Information System" project, which will install anelectronic medical records System ("EMR") and ancillary systems in each oftheir establishments. This multi-million Euro award is led by Agfa Healthcare(Euronext: AGFB - FWB: AGE), which directs the consortium that also includesCap Gemini, HP, Oracle and Global Med-Inlog.
Benoit Leclercq, Chief Executive Officer of the AP-HP, commented about theClinical Information System, "I am pleased with this collaboration, whichresults in a significant improvement in the handling of patients."
EdgeTrack will ensure the complete tracking of blood products with realtime communication with the computerized Agfa EMR System, ORBIS(TM). Theapplication will interface with the French Blood Establishment ("EFS") whichis also equipped with the Global Med-Inlog complete blood management solution,EdgeBlood. All 2.2 million units of blood collected in France are processedby the EdgeBlood product, marketed as "CTS Serveur" in France.
Since EdgeTrack was introduced into the market in 1995 as "Hemo Serveur",it has become a leading hospital transfusion and traceability informationmanagement system in France with more than 100 licensed hospitals. EdgeTrackis connected with most laboratory management systems and hospital informationsystems, and is integrated with major blood transfusion information systems.
Thomas F. Marcinek, President and Chief Operating Officer for Global MedTechnologies, commented, "We are honored to be part of one of the largesthealthcare information technology projects in Europe, and to have been chosento collaborate on this ambitious project by such an elite group of healthcaretechnology companies as Agfa and Cap Gemini. We look forward to supportingAP-HP facilities with quality products and services as they continue toprovide excellent, advanced healthcare to patients and the Paris community."
About AP-HP (Assistance Publique - Hopitaux de Paris)
The Assistance Publique - Hopitaux de Paris is a public healthestablishment serving the city of Paris. It undertakes the missions of health,education, medical research, prevention, healthcare education and emergencymedical care. It includes the University Hospital Centre of theIle-de-France.
The AP-HP is made up of 37 hospitals or hospital groups and hospice care,which were joined in June 2003 into 4 university hospital groups: North, East,South and West. These groups allow the delivery of patient care, which isadapted to the specialties of each health domain in accordance with otherhospital partners. The AP-HP is engaged in a modernization process of thewhole establishment, which proves their dedication to provide safe andinnovative patient care.
For more information on AP-HP, visit their website at http://www.ap-hp.fr.
About Global Med Technologies(R), Inc.
Global Med Technologies, Inc. is an international medical software companywhich develops regulated and non-regulated software products and services forthe healthcare industry. As a leading provider of blood and laboratorysoftware applications and services, Global Med's products are deployed in 20countries and serve over 1,600 transfusion centers, blood banks andlaboratories.
Global Med's domestic companies are Wyndgate Technologies(R), whichprovides Vein-to-Vein(R) tracking through its Donor Doc(TM), SafeTrace(R),SafeTrace Tx(R) and ElDorado Donor(TM) software products; eDonor(R), whichprovides a web-based donor relationship management system that integratesrecruitment, scheduling, retention and fulfillment for national as well aslocal community blood centers and hospitals; and PeopleMed(TM), Inc., whichimplements cost-effective customized software validation, consulting andcompliance solutions to hospitals and donor centers.
Global Med's European subsidiary, Inlog, SA, is a leading developer ofdonor center and transfusion management systems as well as cellular therapysoftware, laboratory information systems and quality assurance medicalsoftware systems internationally. Inlog's products include EdgeBlood*,EdgeTrack*, EdgeCell, EdgeLab and SapaNet.
For more information about Global Med's products and services, please call800-996-3428 or visit http://www.globalmedtech.com, http://www.peoplemed.com,http://www.inlog.com, http://www.eDonor.com, and http://www.wyndgate.com.
*FDA 510(k) clearance required prior to sales in the U.S.
This news release may include statements that constitute forward-lookingstatements, usually containing the words "believe," "estimate," "project,""expects" or similar expressions. These statements are made pursuant to thesafe harbor provisions of the Private Securities Litigation Reform Act of1995. Forward-looking statements inherently involve risks and uncertaintiesthat could cause actual results to differ materially from the forward-lookingstatements. By making these forward-looking statements, the Companyundertakes no obligation to update these statements for revisions or changesafter the date of this news release.
SOURCE Global Med Technologies, Inc.